TBC1D7 Antibodies

Santa Cruz Biotechnology features a diverse variety of TBC1D7 monoclonal antibodies for research focused on understanding TBC1D7's role in cellular processes. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TBC1D7 is a member of the TBC (Tre-2/Bub2/CDC16) domain family, which plays an essential role in regulating cellular signaling pathways and vesicle trafficking. TBC1D7 influences cell growth, differentiation, and metabolism, making it a significant focus in cancer and metabolic disorder research. Research has shown TBC1D7's involvement in multiple cellular pathways, highlighting its importance in understanding disease mechanisms. Ongoing studies continue to reveal new functions of TBC1D7 in cellular regulation and homeostasis. Advanced research techniques have demonstrated TBC1D7's interaction with various molecular partners, expanding knowledge of its biological significance. Current investigations are exploring TBC1D7's potential as a therapeutic target in various pathological conditions. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of TBC1D7's role in health and disease.